| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 4,992 | |||
| Restricted cash | 567 | |||
| Short-term marketable securities | 144,821 | |||
| Cash and cash equivalents | 107,746 | |||
| Assets held for sale | 479 | |||
| Total current assets | 258,605 | |||
| Total assets | 258,605 | |||
| Operating lease liabilities, current | 578 | |||
| Accounts payable | 8,668 | |||
| Accrued restructuring costs | 10,646 | |||
| Accrued expenses and other current liabilities | 739 | |||
| Accrued clinical and research and development expenses | 277 | |||
| Total current liabilities | 20,908 | |||
| Operating lease liabilities, non-current | 0 | |||
| Total liabilities | 20,908 | |||
| Accumulated deficit | -447,083 | |||
| Common stock | 46 | |||
| Additional paid-in capital | 684,743 | |||
| Accumulated other comprehensive income | -9 | |||
| Total stockholders' equity | 237,697 | |||
| Total liabilities and stockholders' equity | 258,605 | |||
CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics, Inc. (CRGX)